Increasing Prevalence of Lifestyle Related Disorders
The rising prevalence of lifestyle related to disorders is one of the primary factors driving the vascular access device market. These include diseases such as cardiovascular diseases, diabetes, and obesity, amongst others. Obesity and overweight are the most common diseases among youth globally. As per the 2017 study published in the Scientific Research Publication, the rate and risk of cancers among students in Europe and North America are similar and increasing at a significant rate. A substantial difference in cancer rate was observed in Western countries and developing countries with less incidence rate. However, over 61% of annual deaths in India are due to lifestyle or non-communicable diseases (NCDs) particularly due to shortage of technical advancement and workforce potential in the hospitals. Thus, with the increased rate of hospitalizations, the global demand for vascular access device advances.
Other driving factors for this market are the rising number of chemotherapy procedures, increased use of vascular access devices in pediatric patients, and surging medical tourism.
High Risk of Diseases Associated with Catheter Use
The high risk of diseases associated with the long use of catheters is one of the major factors restricting the growth of this market. In certain patients, the poor veins make them unsuitable for the placement of the catheter, and in others, long-term access to the veins raises the risk of vein damages. Also, catheter-related bloodstream infection (CRBSI) is among the most common, lethal and high cost associated complications of the central venous catheterization. This increases both intensive care unit (ICU) stay and mortality rate. Therefore, these factors leads to impedance of vascular access devices market.
Other factors impeding this market are stringent regulations related to medical devices approval and product recalls and failures.
Asia-Pacific Provides Vast Opportunities
The Asia-Pacific region is expected to grow at a healthy CAGR between the periods 2018 to 2023 and should provide huge investment opportunities for the vascular device companies in countries, such as India, China, and Japan. These countries have shown a high rate of economic growth in recent years and have a large population with diversified patient pool. With improving healthcare facilities due to the involvement of private sectors companies collaborating with multinational companies and government authorities.
The North America region is expected to dominate the market share in the forecast period due to the well-developed healthcare infrastructure, high awareness in society for early diagnosis of diseases and high adoption of new technologies.
Key Developments in the Market
- April 2018: Cardiva Medical, vascular closure system (Vascade) received approval in patients undergoing interventional cardiac catheterization procedures.
- April 2018: REVA Medical, Inc. initiated commercial operations in partnership with Kardionet HealthCare and Foreign Trading, Ltd (“Kardionet”) for Fantom bioresorbable scaffold access to patients.
Reasons to Purchase the Repor:t
- Current and future of vascular access device market outlook in the developed and emerging markets.
- Analysis of various perspectives of the market with the help of Porter’s Five Forces Analysis.
- The segment that is expected to dominate the market.
- Regions that are expected to witness the fastest growth during the forecast period.
- Identify the latest developments, market shares, and strategies employed by the major market players.
- 3-month analyst support, along with the Market Estimate sheet (in Excel).
This report can be customized to meet your requirements. Please contact us for more information.
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry
6. Market Dynamics
6.1.1 Increasing Prevalence of Lifestyle-related Disorders
6.1.2 Increasing Number of Chemotherapy Procedures with High Hospitalization Rates
6.1.3 Rising Use of Vascular Access Devices in Pediatric Patients
6.1.4 Rising Medical Tourism
6.2.1 Risks Associated with Catheter Use
6.2.2 Stringent Regulations
6.2.3 Product Recalls and Failures
6.4 Key Challenges
7. Market Segmentation
7.1 By Device Type
7.1.1 Central Vascular Access Devices
220.127.116.11 Peripherally Inserted Central Catheters
18.104.22.168 Tunneled Catheters
22.214.171.124 Percutaneous Non-tunneled Catheters
126.96.36.199 Implanted Ports
7.1.2 Peripheral Vascular Access Devices
188.8.131.52 Peripheral Catheter
184.108.40.206 Midline Catheter
7.2 By Application
7.2.1 Administration of Drugs
7.2.2 Administration of Fluid and Nutrition
7.2.3 Diagnotics and Testing
7.3 By End User
7.3.2 Diagnostic Centers
7.4 By Geography
7.4.1 North America
220.127.116.11 United States
18.104.22.168 Rest of North America
22.214.171.124 United Kingdom
126.96.36.199 Rest of Europe
188.8.131.52 South Korea
184.108.40.206 Rest of Asia-Pacific
7.4.4 Middle East & Africa
220.127.116.11 South Africa
18.104.22.168 Rest of Middle East & Africa
7.4.5 South America
22.214.171.124 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 B. Braun Melsungen AG
9.3 Becton, Dickinson and Company
9.4 Fresenius Medical Care AG & Co. KGaA
9.5 Medtronic PLC
9.6 Nipro Medical Corporation
9.7 Siemens Healthineers
9.8 Smiths Medical, Inc.
9.9 Teleflex Incorporated
9.10 Terumo Corporation
*List not Exhaustive
10. Future of the Market
- B. Braun Melsungen Ag
- Dickinson And Company
- Fresenius Medical Care Ag & Co.
- Medtronic Plc
- Nipro Medical Corporation
- Siemens Healthineers
- Smiths Medical Inc.
- Teleflex Incorporated
- Terumo Corporation